Gala FIH Feasibility Study for the Treatment of Chronic Bronchitis

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

November 30, 2019

Conditions
Chronic Bronchitis
Interventions
DEVICE

Gala Airway Treatment System

The Gala Airway Treatment system is a device-based, energy delivery system that delivers high frequency short duration energy to the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope. In this study, 2 treatment sessions will be delivered 1 month apart. The right lung is treated at the first treatment session and the left lung is treated at the second treatment session. A third bronchoscopy will be performed 3 months following the second treatment session where treatment is not delivered but a cryo-biopsy will be taken from the airway sites that have been treated during the two previous bronchoscopic treatment session to evaluate the effect of the treatment on the airways producing excessive mucous. Subjects will be required to submit to several tests during the study including two CT scans (lung), respiratory function tests, exercise testing.

Trial Locations (2)

A-1140

Otto Wagner Spital, Vienna

Unknown

Clinica Alemana, Santiago

Sponsors
All Listed Sponsors
lead

Gala Therapeutics, Inc.

INDUSTRY